• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

()基因变异:北印度人群膀胱癌风险预测中的一种假定癌症干细胞标志物。

() Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.

作者信息

Verma Archana, Kapoor Rakesh, Mittal Rama Devi

机构信息

Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, Uttar Pradesh 226014 India.

出版信息

Indian J Clin Biochem. 2017 Mar;32(1):74-83. doi: 10.1007/s12291-016-0580-y. Epub 2016 May 21.

DOI:10.1007/s12291-016-0580-y
PMID:28149016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5247376/
Abstract

CD44 is involved in cancer-cell growth, invasion, proliferation and metastasis and is also a causal factor for acquisition of resistance to apoptosis. Therefore we evaluated different SNPs of gene viz. , , , and for bladder cancer risk in North Indian population. 240 bladder cancer patients and 270 cancer free controls were recruited in this study. Genotyping was done by PCR-RFLP for . However, , , and were genotyped by allelic discrimination Taqman assay. Statistical analysis was done by SPSS. In-silico analysis was done using F-SNP. We found reduced risk in variant genotype, TT of rs4755392 ( = 0.011) as well as in variant allele, T ( = 0.045). No risk was seen in rs13347, heterozygous genotype, CT ( = 0.023) and variant allele, T ( = 0.007). The dominant model, CT + TT also revealed reduced risk ( = 0.009). A marginal risk was seen in dominant model, GT + TT of rs353639 ( = 0.044) and reduced risk in variant allele T ( = 0.040). A significant manifold risk was seen in smokers carrying variant genotype, TT of ( = 0.038, OR 1.960). Haplotypic analysis revealed significant association in 4 sets viz. TCCGG  = 0.005, TTCGA  = 0.039, ACTGG  = 0.008 and TCTGA  = 0.006. In-silico analysis using F-SNP, showed altered transcriptional regulation for rs187115, rs13347 and rs353639. Our study suggests that rs353639 shows a marginal risk for bladder cancer susceptibility, whereas rs4755392 and rs13347 have reduced risk of bladder cancer and rs187115 and rs187116 had no effect on bladder cancer susceptibility in North Indians.

摘要

CD44参与癌细胞的生长、侵袭、增殖和转移,也是导致细胞对凋亡产生抗性的一个因素。因此,我们评估了该基因的不同单核苷酸多态性(SNPs),即rs187115、rs13347、rs353639、rs4755392和rs187116在北印度人群中患膀胱癌的风险。本研究招募了240例膀胱癌患者和270例无癌对照。rs4755392采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)进行基因分型。然而,rs187115、rs13347、rs353639和rs187116采用Taqman等位基因鉴别分析进行基因分型。使用SPSS进行统计分析。使用F-SNP进行电子分析。我们发现rs4755392的变异基因型TT(P = 0.011)以及变异等位基因T(P = 0.045)的风险降低。rs13347的杂合基因型CT(P = 0.023)和变异等位基因T(P = 0.007)未发现风险。显性模型CT + TT也显示风险降低(P = 0.009)。rs353639的显性模型GT + TT存在边缘风险(P = 0.044),变异等位基因T的风险降低(P = 0.040)。携带rs187116变异基因型TT的吸烟者存在显著的多重风险(P = 0.038,比值比1.960)。单倍型分析显示在4组中存在显著关联,即TCCGG(P = 0.005)、TTCGA(P = 0.039)、ACTGG(P = 0.008)和TCTGA(P = 0.006)。使用F-SNP进行的电子分析显示,rs187115、rs13347和rs353639的转录调控发生改变。我们的研究表明,rs353639对膀胱癌易感性显示出边缘风险,而rs4755392和rs13347降低了患膀胱癌的风险,rs187115和rs187116对北印度人膀胱癌易感性没有影响。

相似文献

1
() Gene Variants: A Putative Cancer Stem Cell Marker in Risk Prediction of Bladder Cancer in North Indian Population.()基因变异:北印度人群膀胱癌风险预测中的一种假定癌症干细胞标志物。
Indian J Clin Biochem. 2017 Mar;32(1):74-83. doi: 10.1007/s12291-016-0580-y. Epub 2016 May 21.
2
CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.CD44 基因多态性与乳腺癌风险和预后的关系:一项在印度北部人群中的研究。
PLoS One. 2013 Aug 5;8(8):e71073. doi: 10.1371/journal.pone.0071073. Print 2013.
3
Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.CD44中的癌症干细胞基因变异可预测II期和III期结肠癌患者的预后。
Anticancer Res. 2017 Apr;37(4):2011-2018. doi: 10.21873/anticanres.11545.
4
Genetic Variation in Gene and Its Association with Bladder Cancer Risk in North Indian Population.北印度人群中某基因的遗传变异及其与膀胱癌风险的关联。
Indian J Clin Biochem. 2017 Jul;32(3):292-300. doi: 10.1007/s12291-016-0606-5. Epub 2016 Aug 26.
5
Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.FSCN1 rs3801004 C/G 和 CD44 rs353639 A/C 基因多态性与埃及乳腺癌患者的预后相关。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3517-3523. doi: 10.31557/APJCP.2023.24.10.3517.
6
Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis.CD44基因rs13347 C>T多态性与亚洲人患癌风险的正相关关系:一项系统评价和荟萃分析。
Onco Targets Ther. 2016 Jun 13;9:3493-500. doi: 10.2147/OTT.S104734. eCollection 2016.
7
Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.CD44基因多态性对台湾地区膀胱移行细胞癌风险的影响。
Tumour Biol. 2016 May;37(5):6971-7. doi: 10.1007/s13277-015-4566-9. Epub 2015 Dec 12.
8
Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.基质金属蛋白酶-2、8 基因启动子中单核苷酸多态性与印度北部膀胱癌风险的关联。
Urol Oncol. 2013 Feb;31(2):247-54. doi: 10.1016/j.urolonc.2011.01.001. Epub 2011 Jul 23.
9
Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.印度北部人群中半胱天冬酶9和半胱天冬酶8基因多态性与膀胱癌易感性
Ann Surg Oncol. 2009 Jul;16(7):2028-34. doi: 10.1245/s10434-009-0488-3. Epub 2009 May 2.
10
Common polymorphisms in CD44 gene and susceptibility to cancer: A systematic review and meta-analysis of 45 studies.CD44基因常见多态性与癌症易感性:45项研究的系统评价与荟萃分析
Oncotarget. 2016 Nov 15;7(46):76021-76035. doi: 10.18632/oncotarget.12580.

引用本文的文献

1
Circular RNAs in cancer stem cells: Insights into their roles and mechanisms (Review).癌症干细胞中的环状RNA:对其作用和机制的见解(综述)
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2025.5491. Epub 2025 Jan 24.
2
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.三阴性乳腺癌上皮-间质转化的靶向治疗方法
Front Oncol. 2024 Oct 10;14:1431418. doi: 10.3389/fonc.2024.1431418. eCollection 2024.
3
CD44 rs13347C>T Variants in 3'UTR and Prostate Neoplasms: A Case-control Study and Bioinformatics Approach.3'非翻译区的CD44 rs13347C>T变异与前列腺肿瘤:一项病例对照研究及生物信息学方法
Int J Mol Cell Med. 2023;12(3):275-287. doi: 10.22088/IJMCM.BUMS.12.3.275.
4
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy.肿瘤微环境:癌症干细胞免疫治疗的龛位。
Stem Cell Rev Rep. 2024 Jan;20(1):3-24. doi: 10.1007/s12015-023-10639-6. Epub 2023 Oct 20.
5
Mutant Allele of CD44 (rs8193C>T) and Pum2 Regulatory Element as A Prognosis Factor of Prostate Neoplasms: A Case-Control and In Silico Studies.CD44的突变等位基因(rs8193C>T)和Pum2调控元件作为前列腺肿瘤的预后因素:一项病例对照研究和计算机模拟研究
Cell J. 2022 Dec 1;24(12):723-731. doi: 10.22074/cellj.2022.8468.
6
Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer.肌肉浸润性膀胱癌分子表型的瘤内转换与总生存期
Cancers (Basel). 2022 Jul 2;14(13):3256. doi: 10.3390/cancers14133256.
7
Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting.癌症干细胞:从基础认知到最新进展与治疗靶点
Stem Cells Int. 2022 Jun 28;2022:9653244. doi: 10.1155/2022/9653244. eCollection 2022.
8
Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.用于CD44靶向小干扰RNA递送以治疗膀胱癌的可自交联壳聚糖-透明质酸二醛纳米颗粒
Bioact Mater. 2020 Sep 8;6(2):433-446. doi: 10.1016/j.bioactmat.2020.08.019. eCollection 2021 Feb.
9
Targeting cancer stem cell pathways for cancer therapy.针对癌症干细胞通路的癌症治疗。
Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5.
10
Association of CD44 gene rs187115 polymorphism with colorectal cancer risk and prognosis in Chinese Han population: a case-control study.CD44基因rs187115多态性与中国汉族人群结直肠癌风险及预后的关联:一项病例对照研究
Aging (Albany NY). 2019 Nov 3;11(21):9616-9625. doi: 10.18632/aging.102408.

本文引用的文献

1
Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.骨桥蛋白(OPN)及其受体CD44基因与中国胃癌患者易感性的遗传关联。
J Cancer Res Clin Oncol. 2014 Dec;140(12):2143-56. doi: 10.1007/s00432-014-1761-9. Epub 2014 Jul 10.
2
CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.台湾地区CD44基因多态性与环境因素对口腔癌易感性的影响
PLoS One. 2014 Apr 3;9(4):e93692. doi: 10.1371/journal.pone.0093692. eCollection 2014.
3
Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population.北印度人群中癌症干细胞基因CD44单倍型的遗传变异与胆囊癌易感性的关联
Tumour Biol. 2014 Mar;35(3):2583-9. doi: 10.1007/s13277-013-1340-8. Epub 2013 Nov 5.
4
CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.CD44 基因多态性与乳腺癌风险和预后的关系:一项在印度北部人群中的研究。
PLoS One. 2013 Aug 5;8(8):e71073. doi: 10.1371/journal.pone.0071073. Print 2013.
5
Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population.CD44 基因多态性与中国人群鼻咽癌易感性的关系。
Mutagenesis. 2013 Sep;28(5):577-82. doi: 10.1093/mutage/get035. Epub 2013 Jul 24.
6
Role of CD44 as a marker of cancer stem cells in head and neck cancer.CD44作为头颈部癌中癌症干细胞标志物的作用。
Biologics. 2012;6:379-83. doi: 10.2147/BTT.S37906. Epub 2012 Nov 1.
7
CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.CD44基因rs13347位点C>T多态性可预测中国人群的乳腺癌风险及预后。
Breast Cancer Res. 2012 Jul 12;14(4):R105. doi: 10.1186/bcr3225.
8
Developmental reprogramming of cancer susceptibility.癌症易感性的发育重编程。
Nat Rev Cancer. 2012 Jun 14;12(7):479-86. doi: 10.1038/nrc3220.
9
shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.shRNA 靶向 CD44 抑制结肠癌细胞增殖、侵袭和迁移,并促进其凋亡。
Oncol Rep. 2012 Feb;27(2):339-46. doi: 10.3892/or.2011.1532. Epub 2011 Nov 8.
10
Common cancer stem cell gene variants predict colon cancer recurrence.常见的癌症干细胞基因变异可预测结肠癌复发。
Clin Cancer Res. 2011 Nov 1;17(21):6934-43. doi: 10.1158/1078-0432.CCR-11-1180. Epub 2011 Sep 14.